🇺🇸 AMGN — Amgen Inc.

Salud Mantener
← Volver

Precio actual

461,26 USD

Máx. histórico

466,01

4 días

Split 2:1 del 22/11/1999

Caída desde máximo

-1,02%

Rango 52 semanas

294,48 – 475,65

Variación hoy

-0,90%

Cierre anterior

465,45

Rango de hoy

460,15 – 467,02

Volumen hoy

2.351.852

Peor caída histórica

-78,03%

17/06/1983 → 19/11/1984

Recuperado en 487 días

Volatilidad anualizada ⓘ

37,45%

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
28,65 (puede no estar actualizado)
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
397,32 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 14 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,15%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/06/2023 219,62 221,66 218,88 221,16 -0,07% 1,27% 1.860.300
28/06/2023 222,24 222,35 218,65 221,31 -0,58% 1,66% 2.263.400
27/06/2023 224,16 224,64 221,13 222,61 -0,94% 1,57% 2.705.900
26/06/2023 226,80 226,80 220,12 224,73 -1,05% 2,95% 2.565.500
23/06/2023 229,87 230,54 226,41 227,11 -1,11% 1,80% 4.130.700
22/06/2023 227,31 229,88 226,76 229,66 +1,15% 1,37% 1.607.200
21/06/2023 228,18 230,00 225,59 227,04 -0,68% 1,93% 2.282.600
20/06/2023 229,03 230,84 227,19 228,59 -0,47% 1,59% 2.492.700
16/06/2023 230,04 231,95 227,75 229,66 +0,53% 1,83% 6.765.000
15/06/2023 223,01 228,85 222,97 228,44 +2,77% 2,64% 2.633.900
14/06/2023 223,26 223,69 221,10 222,28 +0,13% 1,16% 2.453.000
13/06/2023 217,43 222,34 216,93 221,99 +2,13% 2,49% 2.318.500
12/06/2023 219,25 219,25 215,32 217,36 -0,64% 1,79% 2.704.300
09/06/2023 219,34 220,94 217,77 218,76 -0,91% 1,45% 1.707.900
08/06/2023 221,26 221,89 219,36 220,76 -0,22% 1,14% 1.877.300
07/06/2023 220,76 221,87 219,73 221,25 +0,01% 0,97% 2.555.400
06/06/2023 223,08 223,17 219,28 221,22 -0,30% 1,74% 1.736.100
05/06/2023 219,67 223,04 218,47 221,88 +1,75% 2,08% 2.498.700
02/06/2023 213,75 218,76 212,02 218,07 +1,77% 3,15% 3.687.200
01/06/2023 219,96 220,60 211,71 214,27 -2,89% 4,04% 4.831.400
31/05/2023 219,58 221,85 217,19 220,65 +0,97% 2,12% 3.884.700
30/05/2023 215,03 219,00 214,72 218,53 +0,74% 1,99% 3.125.900
26/05/2023 215,96 218,48 214,48 216,93 -0,24% 1,85% 3.081.000
25/05/2023 220,10 220,10 214,93 217,46 -1,74% 2,35% 2.968.200
24/05/2023 225,64 225,96 221,04 221,32 -1,39% 2,18% 1.765.000
23/05/2023 224,21 226,82 222,80 224,44 +0,20% 1,79% 2.296.600
22/05/2023 224,85 226,82 222,82 223,99 +0,26% 1,78% 1.848.600
19/05/2023 224,44 225,88 222,78 223,42 -0,36% 1,38% 2.395.700
18/05/2023 224,75 224,75 221,92 224,23 -0,35% 1,26% 2.245.300
17/05/2023 226,02 226,09 220,44 225,02 -1,26% 2,50% 3.352.900